FDA OKs Phase 2 Study of Antria’s Stem Cell Technology in Plastic Surgery
Antria Inc announced that the FDA has approved a Phase 2 study of autologous adipose derived stem cells in plastic surgery. The future is now. #regenerativemedicine
Antria Inc announced that the FDA has approved a Phase 2 study of autologous adipose derived stem cells in plastic surgery. The future is now. #regenerativemedicine
The tool consolidates prescription workflows into a single platform and includes DEA-compliant identity verification for controlled substance prescribing.